Canada markets closed

Mirum Pharmaceuticals, Inc. (MIRM)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
25.92-0.76 (-2.85%)
At close: 04:00PM EDT
25.92 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.22B
Enterprise Value 1.23B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)5.00
Price/Book (mrq)5.21
Enterprise Value/Revenue 5.47
Enterprise Value/EBITDA -5.66

Trading Information

Stock Price History

Beta (5Y Monthly) 1.10
52-Week Change 3-8.51%
S&P500 52-Week Change 323.76%
52 Week High 335.56
52 Week Low 323.14
50-Day Moving Average 325.15
200-Day Moving Average 328.02

Share Statistics

Avg Vol (3 month) 3482.02k
Avg Vol (10 day) 3660.96k
Shares Outstanding 547.13M
Implied Shares Outstanding 648.55M
Float 835.37M
% Held by Insiders 12.23%
% Held by Institutions 1118.75%
Shares Short (May 15, 2024) 48.81M
Short Ratio (May 15, 2024) 421.95
Short % of Float (May 15, 2024) 421.78%
Short % of Shares Outstanding (May 15, 2024) 418.70%
Shares Short (prior month Apr 15, 2024) 48.58M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -70.79%
Operating Margin (ttm)-38.24%

Management Effectiveness

Return on Assets (ttm)-13.76%
Return on Equity (ttm)-84.40%

Income Statement

Revenue (ttm)224M
Revenue Per Share (ttm)5.18
Quarterly Revenue Growth (yoy)119.10%
Gross Profit (ttm)N/A
EBITDA -93.32M
Net Income Avi to Common (ttm)-158.56M
Diluted EPS (ttm)-3.74
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)302.84M
Total Cash Per Share (mrq)6.43
Total Debt (mrq)307.52M
Total Debt/Equity (mrq)131.08%
Current Ratio (mrq)3.68
Book Value Per Share (mrq)4.99

Cash Flow Statement

Operating Cash Flow (ttm)-36.96M
Levered Free Cash Flow (ttm)-15.42M